An assessment of antimicrobial prescribing at a tertiary hospital in north-western Nigeria

Samirah N Abdu-Aguye, Adamu Haruna, Aishatu Shehu, Kamilu S Labaran

Abstract


Background: Inappropriate antibiotic use is a public health problem worldwide. Misuse of these agents is one of the drivers of antimicrobial resistance (AMR), which is believed to be the next pandemic. Consequently, auditing antimicrobial prescription patterns can provide useful information on the scope and extent of this problem.

Objective: The aim of this study was to describe outpatient antimicrobial drug prescribing at the National Health Insurance Scheme (NHIS) unit of Ahmadu Bello University Teaching Hospital, Zaria, Nigeria.

Methodology: This was a descriptive drug utilization study carried out prospectively during a 2 week period in May 2015. Six objective World Health Organization (WHO) indicators were used to assess the rationality of antimicrobial prescribing at the site. Data collected on antimicrobials included type, route of administration, dose and dosing frequency as well as length of therapy. Average costs (both prescription and antibiotic) were obtained by dividing the total drug costs by the relevant number of drugs.

Results: A total of 167 prescriptions were analyzed. The average number of drugs per encounter in the facility was 3.7. Fifty seven percent of antimicrobials were prescribed using their generic names, while the average duration of treatment was 8.9 days. Thirty seven prescriptions (22%) contained more than one prescribed antimicrobial, out of which 7 were potentially pharmacologically antagonistic. Only 21% of the prescriptions had indications in line with the National Standard Treatment Guidelines (STG’s). Average cost of prescribed antimicrobials was about NGN 2,238 (approximately US$11).

Conclusion: Several problems associated with rational antimicrobial prescribing were identified. There is a definite need for suitable interventions to help improve antimicrobial drug prescribing at the site.

Keywords: Anti-infective agents, Costs, Drug use review, National Health Insurance, Nigeria


References


Abula T and Kedir M (2004). The pattern of antibiotic usage in surgical in-patients of a teaching hospital, northwest Ethiopia. Ethiop. J. Health Dev. 18: 35-38.

Adebayo ET and Hussain NA (2010). Pattern of prescription drug use in Nigerian army hospitals. Ann. Afr. Med. 3: 152-158.

Akande TM, Ologe M and Medubi GF (2009). Antibiotic Prescription Pattern and Cost at University of Ilorin Teaching Hospital, Ilorin, Nigeria. Int. J. Trop. Med. 4: 50-54.

Anyanwu NC and Arigbe-Osula ME (2012). Pattern of antibiotic use in a tertiary hospital in Nigeria. Eur. J. Hosp. Pharm. 19: 195-199.

Babalola CP, Awoleye SA, Akinyemi JO and Kotila OA (2011). Evaluation of prescription pattern in Osun State (Southwest) Nigeria. J. Public Health Epidemiol. 3: 94-98.

Chukwuani CM, Onifade M and Sunmonu K (2002). Survey of drug use practices and antibiotic prescribing pattern at a general hospital in Nigeria. Pharm. World Sci. 24: 188-195.

Duerden M, Avery T and Payne R (2013). Polypharmacy and Medicines Optimization, 1st Edition. The Kings Fund, London. 2013.

Food and Drug Administration. FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes. www.fda.gov/Drugs/DrugSafety/ucm451800.htm (Accessed 26 November 2015).

Fernandes M, Leite A, Basto M, Nobre M, Vieira N, Fernandes R, Nogueira P and Nicola PJ (2013). Non-adherence to antibiotic therapy in patients visiting community pharmacies. Int. J. Clin. Pharm. 36: 86-91.

Federal Ministry of Health, Nigeria (2008). Standard Treatment Guidelines (STG).

Gill JM, Fleischut P, Haas S, Pellini B, Crawford A and Nash DB (2006). Use of antibiotics for adult upper respiratory infections in outpatient settings: a national ambulatory network study. Fam. Med. 38: 349–354.

Holloway K and van Dijk L (2011). The World Medicines Situation Report 2011. World Health Organization, Geneva, pp. 1-18.

Maiyaki MB and Garbati MA (2014). The burden of non-communicable diseases in Nigeria; in the context of globalization. Ann. Afr. Med. 13: 1-10.

Malcolm W, Nathwani D, Davey P, Cromwell T, Patton A, Reilly J, Cairns S and Bennie M (2013). From intermittent antibiotic point prevalence surveys to quality improvement: experience in Scottish hospitals. Antimicrob. Resist. Infect Control. 2: 3-12.

Mgbahurike AA, Idowu I and Igwilo CI (2010). Antibiotic Utilization and Prescribing Patterns in a Nigerian University Medical Center. Nig. J. Pharm. Res. 8: 236-241.

Management Sciences for Health (2012). How to Investigate Antimicrobial Use in Hospitals: Selected Indicators. Virginia, Strengthening Pharmaceutical Systems Program.

National Prescribing Service. Duration of antibiotic therapy and resistance. www.nps.org.au/publications/health-professional/health-news-evidence/2013/duration-of-antibiotic-therapy (Accessed 1 December 2015).

Ntšekhe MN, Hoohlo-Khotle N, Tlali M and Tjipura D (2012). Antibiotic Prescribing Patterns at Six Hospitals in Lesotho. Virginia, Strengthening Pharmaceutical Systems (SPS) Program.

Odusanya OO (2005). Drug use indicators at a secondary health care facility in Lagos, Nigeria. J. Comm. Med. Prim. Health Care. 16: 21-24.

Sánchez-Delgado J, García-Iglesias P, Castro-Fernández M, Bory F, Barenys M, Bujanda L, Lisozain J, Calvo MM, Torra S, Gisbert JP and Calvet X (2012). High-dose, Ten-day Esomeprazole, Amoxicillin and Metronidazole Triple Therapy Achieves High Helicobacter Pylori Eradication Rates. Aliment. Pharmacol. Ther. 36: 190-196.

Tamuno I and Fadare JO (2012). Drug Prescription Pattern in a Nigerian Tertiary Hospital. Trop. J. Pharm. Res. 11: 146-152.

World Health Organization (2003). Global defense against the infectious diseases threat. Geneva, World Health Organization.

World Health Organization (2014). Antimicrobial Resistance: Global report on surveillance. Geneva, WHO document production services.

Williams A, Phillips AS and Mathai AS (2011). Antibiotic prescription patterns at admission into a tertiary level intensive care unit in Northern India. J. Pharm. Bioallied Sci. 3: 531-536.


Full Text: PDF

Refbacks

  • There are currently no refbacks.